SCHEMBL22947650

SCHEMBL22947650

c1ccc(-c2nc(-c3ccncc3)nc(-c3ccc(-c4cccc5c4-c4ccccc4S5(c4ccccc4)c4ccccc4)cc3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.42
MAPT P10636 4/20 0.42
TSHR P16473 2/20 0.42
ALDH1A1 P00352 2/20 0.42
HTT P42858 1/20 0.42
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
HSD17B10 Q99714 2/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
TNF P01375 1/20 0.36
KCNA5 P22460 1/20 0.36
KCNH2 Q12809 1/20 0.36
NOTUM Q6P988 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
ADORA2A P29274 2/20 0.35
ADORA1 P30542 2/20 0.35
ADORA3 P0DMS8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947375 0.93 SMN1; SMN2 (0.40) SMN1; SMN2MAPTTSHRALDH1A1HTT
SCHEMBL22947525 0.93 ADORA3 (0.39) SMN1; SMN2MAPTTSHRALDH1A1HSD17B10
SCHEMBL22947671 0.92 ADORA3 (0.38) SMN1; SMN2MAPTTSHRALDH1A1HSD17B10
SCHEMBL22949087 0.91 SMN1; SMN2 (0.38) SMN1; SMN2MAPTTSHRALDH1A1HTT
SCHEMBL22947430 0.89 ALDH1A1 (0.43) SMN1; SMN2MAPTTSHRALDH1A1HTT
SCHEMBL22947637 0.86 ADORA3 (0.38) SMN1; SMN2MAPTTSHRALDH1A1HSD17B10
SCHEMBL22949634 0.86 ADORA3 (0.38) SMN1; SMN2MAPTTSHRALDH1A1HSD17B10
SCHEMBL22947384 0.86 ADORA2A (0.40) SMN1; SMN2MAPTTSHRALDH1A1HSD17B10
SCHEMBL22948448 0.85 TSHR (0.37) SMN1; SMN2MAPTTSHRALDH1A1HTT
SCHEMBL22947426 0.83 ADORA2A (0.38) SMN1; SMN2MAPTTSHRALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 SMN1; SMN2 3681/4885MAPT 3103/4885TSHR 3468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.